Home About Us Research & Development Investors & Media Careers Contact Us
+ 0.09 (0.70%)
4:00 PM ET on Nov 21, 2014
~20 min. delay


At Concert Pharmaceuticals, we create novel medicines that address medically important needs by applying our DCE Platform® (Deuterated Chemical Entity Platform) to compounds with well-characterized pharmacological activity.  This approach may enable drug discovery and clinical development that is more efficient and less expensive than conventional small molecule drug research and development.

The company was co-founded by Richard Aldrich, Roger Tung and Christoph Westphal, and is located in the historic town of Lexington, Massachusetts.

Press Releases

Nov 12, 2014
Nov 11, 2014

Events & Presentations

There are no upcoming events available at this time. Sign up for email alerts.

IR Contact

Justine E. Koenigsberg
Vice President,
Corporate Communications
and Investor Relations

Letter to Shareholders

Shareholder Letter

[ back to top ]